Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 3”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01445964
What this trial is testing

Effect of SLCO2B1 Genotype and Apple Juice on Pharmacokinetics of Atenolol After Oral Administration in Healthy Male Korean

Who this might be right for
Healthy
Seoul National University Hospital 12
Early research (Phase 1)Study completedNCT01590407
What this trial is testing

First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 71
Testing effectiveness (Phase 2)Study completedNCT00863239
What this trial is testing

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Who this might be right for
Hepatitis C, Chronic
Biolex Therapeutics, Inc. 116
Testing effectiveness (Phase 2)WithdrawnNCT00008866
What this trial is testing

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT02332720
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 413
Large-scale testing (Phase 3)Study completedNCT02243293
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C Virus
AbbVie 694
Large-scale testing (Phase 3)Study completedNCT02960893
What this trial is testing

Trial in Adult Participants With Spinocerebellar Ataxia (SCA)

Who this might be right for
Spinocerebellar AtaxiasSpinocerebellar Ataxia Genotype Type 1Spinocerebellar Ataxia Genotype Type 2+5 more
Biohaven Pharmaceuticals, Inc. 141
Not applicableLooking for participantsNCT06491615
What this trial is testing

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Who this might be right for
Inherited Ophthalmic DiseasesHypopigmentation DisorderCorneal Dystrophy+4 more
National Eye Institute (NEI) 1,000
Large-scale testing (Phase 3)Study completedNCT01542788
What this trial is testing

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 278
Not applicableUnknownNCT03510637
What this trial is testing

"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 7,500
Not applicableStudy completedNCT01718535
What this trial is testing

Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing

Who this might be right for
Genotyping Techniques
Spartan Bioscience Inc. 327
Large-scale testing (Phase 3)WithdrawnNCT01590225
What this trial is testing

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01753557
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Who this might be right for
Chronic Hepatitis C (CHC)
Tanabe Pharma Corporation 54
Testing effectiveness (Phase 2)WithdrawnNCT02551861
What this trial is testing

A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT01753570
What this trial is testing

Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C(CHC)
Tanabe Pharma Corporation 74
Large-scale testing (Phase 3)Study completedNCT01497366
What this trial is testing

Phase 3 Study of Sofosbuvir and Ribavirin

Who this might be right for
Hepatitis C
Gilead Sciences 527
Testing effectiveness (Phase 2)WithdrawnNCT02556086
What this trial is testing

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01458535
What this trial is testing

Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C Virus
AbbVie (prior sponsor, Abbott) 61
Large-scale testing (Phase 3)Study completedNCT00002410
What this trial is testing

Three Different Anti-HIV Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Dupont Merck
Large-scale testing (Phase 3)Study completedNCT01290679
What this trial is testing

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants

Who this might be right for
Hepatitis C
Janssen R&D Ireland 393
Next Page